AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present At Roth Capital Partners Growth Stock Conference SAN DIEGO, Feb. 12 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will be presenting at the Roth Capital Partners Growth Stock Conference on Tuesday, February 17, 2004 at 9:00 a.m. Pacific Time at The St. Regis Monarch Beach Resort in Dana Point, CA. Mark G. Foletta, Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview. The presentation willbe webcast live by Roth Capital Partners, and a recording will be made available approximately one hour following the event. The webcast and recording will be accessible through Amylin's corporate website, http://www.amylin.com/ . To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolicdiseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright